VRA Fundamental Analysis - VERA BRADLEY INC

Fundamental Rating

Overall VRA gets a fundamental rating of 2 out of 10. We evaluated VRA against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. While VRA seems to be doing ok healthwise, there are quite some concerns on its profitability. VRA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VRA has reported negative net income.

VRA had a negative operating cash flow in the past year.

In multiple years VRA reported negative net income over the last 5 years.

In multiple years VRA reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of VRA (-32.67%) is worse than 89.58% of its industry peers.

The Return On Equity of VRA (-59.94%) is worse than 79.17% of its industry peers.

		Industry Rank	Sector Rank
ROA	-32.67%
ROE	-59.94%
ROIC	N/A

ROA(3y)-10.99%

ROA(5y)-5.57%

ROE(3y)-18.49%

ROE(5y)-9.46%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 48.89%, VRA perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

In the last couple of years the Gross Margin of VRA has declined.

VRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	48.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.8%

GM growth 5Y-1.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for VRA has been reduced compared to 1 year ago.

VRA has less shares outstanding than it did 5 years ago.

There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

VRA has an Altman-Z score of 2.41. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.

VRA has a Altman-Z score of 2.41. This is in the lower half of the industry: VRA underperforms 66.67% of its industry peers.

There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.41

ROIC/WACCN/A

WACC9.02%

2.3 Liquidity

VRA has a Current Ratio of 2.28. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.

VRA has a Current ratio of 2.28. This is in the better half of the industry: VRA outperforms 60.42% of its industry peers.

VRA has a Quick Ratio of 2.28. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of VRA (0.61) is worse than 87.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.28
Quick Ratio	0.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -290.48%.

VRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.95%.

VRA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.56% yearly.

EPS 1Y (TTM)-290.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-71.43%

Revenue 1Y (TTM)-24.95%

Revenue growth 3Y-11.71%

Revenue growth 5Y-5.56%

Sales Q2Q%-35.92%

3.2 Future

Based on estimates for the next years, VRA will show a very strong growth in Earnings Per Share. The EPS will grow by 45.22% on average per year.

The Revenue is expected to decrease by -13.28% on average over the next years. This is quite bad

EPS Next Y2.11%

EPS Next 2Y45.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-27.55%

Revenue Next 2Y-13.28%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 30.13, which means the current valuation is very expensive for VRA.

Compared to the rest of the industry, the Price/Forward Earnings ratio of VRA indicates a slightly more expensive valuation: VRA is more expensive than 68.75% of the companies listed in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 22.19. VRA is valued slightly more expensive when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	30.13

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

A more expensive valuation may be justified as VRA's earnings are expected to grow with 45.22% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y45.22%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

VRA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VERA BRADLEY INC

NASDAQ:VRA (6/18/2025, 8:00:01 PM)

After market: 2.13 0 (0%)

2.13

-0.21 (-8.97%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryTextiles, Apparel & Luxury Goods

Earnings (Last)06-11 2025-06-11/bmo

Earnings (Next)09-09 2025-09-09

Inst Owners70.63%

Inst Owner Change-1.89%

Ins Owners7.78%

Ins Owner Change-22.78%

Market Cap59.47M

Analysts80

Price Target4.08 (91.55%)

Short Float %16.96%

Short Ratio11.21

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-377%

Min EPS beat(2)-556.97%

Max EPS beat(2)-197.03%

EPS beat(4)0

Avg EPS beat(4)-330.38%

Min EPS beat(4)-556.97%

Max EPS beat(4)-21.99%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-6.34%

Min Revenue beat(2)-8.31%

Max Revenue beat(2)-4.37%

Revenue beat(4)0

Avg Revenue beat(4)-10.23%

Min Revenue beat(4)-19.17%

Max Revenue beat(4)-4.37%

Revenue beat(8)0

Avg Revenue beat(8)-8.28%

Revenue beat(12)2

Avg Revenue beat(12)-5.52%

Revenue beat(16)2

Avg Revenue beat(16)-5.68%

PT rev (1m)0%

PT rev (3m)-36%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)-157.69%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-36.02%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-29.55%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	30.13
P/S	0.17
P/FCF	N/A
P/OCF	N/A
P/B	0.41
P/tB	0.41
EV/EBITDA	N/A

EPS(TTM)-0.8

EYN/A

EPS(NY)0.07

Fwd EY3.32%

FCF(TTM)-1.02

FCFYN/A

OCF(TTM)-0.61

OCFYN/A

SpS12.29

BVpS5.23

TBVpS5.23

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-32.67%
ROE	-59.94%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	48.89%
FCFM	N/A

ROA(3y)-10.99%

ROA(5y)-5.57%

ROE(3y)-18.49%

ROE(5y)-9.46%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.8%

GM growth 5Y-1.67%

F-Score4

Asset Turnover1.28

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	37.37%
Cap/Sales	3.32%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.28
Quick Ratio	0.61
Altman-Z	2.41

F-Score4

WACC9.02%

ROIC/WACCN/A

Cap/Depr(3y)37.76%

Cap/Depr(5y)36.59%

Cap/Sales(3y)1.74%

Cap/Sales(5y)1.49%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-290.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-71.43%

EPS Next Y2.11%

EPS Next 2Y45.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-24.95%

Revenue growth 3Y-11.71%

Revenue growth 5Y-5.56%

Sales Q2Q%-35.92%

Revenue Next Year-27.55%

Revenue Next 2Y-13.28%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-418.45%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year117.75%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-54.28%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-53.19%

OCF growth 3YN/A

OCF growth 5YN/A

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens